Cengiz M.Yildiz F.Genc M.2020-03-262020-03-2620060028-4793https://dx.doi.org/10.1056/NEJMc060694https://hdl.handle.net/20.500.12395/20781[Abstract not Available]en10.1056/NEJMc060694info:eu-repo/semantics/closedAccessCetuximab plus radiotherapy for head and neck cancer [10]Letter35420218716710908Q1